Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Putting aside Hims meme potential, the company is still in a great position to disrupt the healthcare industry given its unique platform and business model. While Hims is building an increasingly innovative and high-quality business model, the company still faces major regulatory and competitive hurdles.

Ocean Power Technologies Inc (NYSE-A:OPTT) announced that it will demonstrate its WAM-V Unmanned Surface Vehicles (USVs) at NAVDEX in Abu Dhabi, in collaboration with its UAE-based partner, Remah International Group (RIG). This follows RIG's appointment as OPT's regional distributor for defense and security solutions in late 2024.

PDD Holdings' recent share price volatility presents an opportunity for investors to build positions, given its attractive valuation at 9x 2025E earnings and 12% EPS growth outlook. The de minimis exemption on Chinese goods is unlikely to change soon, mitigating potential disruptions to PDD's cross-border e-commerce arm, Temu. PDD's proactive diversification away from a US-centric model and expansion into Southeast Asia supports a bullish outlook, despite tariff uncertainties.

Brandywine Realty Trust is currently at the low point when looking at Funds From Operations due to elevated JV related costs. The company is in a transitional phase, while the market seems to be focused short term. This article provides a detailed analysis (including Q4 2026 FFO estimates) that should provide important information to investors interested in deep value REITs.

The rise of artificial intelligence (AI) and cloud computing has revolutionized business operations while also increasing cybersecurity risks. As threats become more advanced, AI-driven security solutions are now crucial for safeguarding sensitive data, preventing breaches and detecting fraud in real-time.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Cheesecake Factory (CAKE) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Equillium (EQ) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

21Vianet (VNET) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

OSI (OSIS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

StoneX Group (SNEX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Finding the best marijuana stocks to buy gained the interest of more investors over the past few years, with big market drivers being companies entering more states and countries that are moving towards legalizing cannabis for both medical and recreational use. The potential for growth in this sector can be attributed to several key factors. To start is the growing acceptance of cannabis, and companies within this sector now diversifying their offerings. Next would be the many regions currently in various stages of legalizing cannabis.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Novo Nordisk's drastic selloff may be attributed to the management overpromising CagriSema's 25% weight loss target along with the decelerating top-line growth trend. The company now faces numerous headwinds from the Centers for Medicare and Medicaid Services, GLP1 compounders, and new biotech companies. Even so, we believe that the correction has been overly done, with NVO now trading way below its 10Y P/E means and its direct competitors.

Amazon's (NASDAQ: AMZN) Q4 and FY 2024 earnings report, released on February 6, was a double beat. Even though both earnings per share (EPS) and revenue came in above estimates, the markets weren't exactly satisfied.

Even after buying the $1.5 billion in stock, Schwab will still have $7.2 billion remaining under its existing stock-buyback program.

McDonald's global same-store sales climbed 0.4% in the fourth quarter, despite a drop of 1.4% in the US. An E. coli outbreak in the US scared customers away halting some momentum.

ON Semiconductor Corp. (ON) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.25 per share a year ago.

Intel has lost 65% in value since 2021 and has suspended its dividend. Intel's core x86 CPU business is losing market share to AMD, while Intel's gross margin is also far behind its peers. Intel's new leadership faces urgent decisions to avoid falling further behind competitors like AMD, NVIDIA, and TSMC in key growth markets.